Announcements Trials
Browse Landscape

Phase

Phase NA 21Phase 2 19Phase 1/2 4Phase 3 3Phase 1 2

Status

Recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 6Genitourinary 4Dermatologic 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 4Prostatic Diseases 1Adenocarcinoma 1

Interventions

pembrolizumab 69Docetaxel 50Nivolumab 44Prednisone 34enzalutamide 30Gemcitabine 26Cyclophosphamide 22Cisplatin 22Paclitaxel 21Radiotherapy 19Carboplatin 19Bevacizumab 19Abiraterone Acetate 18Ipilimumab 17atezolizumab 14Magnetic Resonance Spectroscopy 14fludarabine 13aldesleukin 13Sunitinib 13Interleukin-2 12avelumab 11Radiosurgery 11Pluvicto 11Filgrastim 11Everolimus 11gallium 68 PSMA-11 10fludarabine phosphate 10enfortumab vedotin 10durvalumab 10cemiplimab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Brachytherapy × Genitourinary × Clear all
NCT03543189 2026-04-01

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Active not recruiting
44 enrolled
Genitourinary

Prostatic Diseases, Prostatic Neoplasms

NCT07182279 2026-03-09

Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer

The Methodist Hospital Research Institute

Phase 1/2 Recruiting
29 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT01913106 2016-07-01

HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

The Methodist Hospital Research Institute

Phase 1/2 Recruiting
25 enrolled
Genitourinary

Prostatic Neoplasms

NCT00005939 2013-11-06

Brachytherapy in Treating Patients With Recurrent Prostate Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡